Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- CheckyesterdayChange DetectedThe website footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check8 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.7.0 was added to the history, replacing the previous v3.6.6. This indicates an update to the page's revision record.SummaryDifference0.0%

- Check49 days agoChange DetectedA new revision entry (151) dated 2026-08-28 adds Study Status, Contacts/Locations, Outcome Measures, and Study Design to the record history and updates the revision to v3.6.6. The history also removes the 2025-12-24 entry for Revision: v3.6.5.SummaryDifference0.3%

- Check71 days agoChange DetectedRecord History now reflects an updated page version, with Revision: v3.6.5 listed instead of v3.6.4. This indicates the study record has been refreshed to a new version in ClinicalTrials.gov.SummaryDifference0.0%

- Check85 days agoChange DetectedThe footer shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a new site update in the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.